|
Spearheading
the Global Expansion of China's Top
Pharma & TCM Firms
|
|
Watch TV Ads
|
Xing
Ling awards exclusive distribution rights for Topsun’s intravenous infusion
range for Cambodia to World Health Pharmaceutical Co., Ltd. WHP Cambodia, an established pharmaceutical sales company in Cambodia signed an exclusive distribution contract to sell Topsun’s range of infusion products to the hospital market in this emerging country, which boasts higher GDP growth rates than China. WHP has already started the registration process with the Cambodian Health Ministry, the approval is expected for end 2006. With an established partner like WHP Cambodia, we can look forward to a successful penetration of the Cambodian market, potentially also for other products. Topsun’s infusion range is produced by its subsidiary Topsun Jisheng Pharmacetical Co.., a Sino-US joint venture with a yearly capacity of 20 million bottles. Jisheng is a leading manufacturer for intravenous infusions in China, e.g. for glucose and sodium chloride injections. |
|
© Copyright
2005-2006 Xing Ling International Pte Ltd. All Rights Reserved.
|